tiprankstipranks
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
US Market
NKTR
Nektar Therapeutics
RESEARCH TOOLSreports

Nektar Therapeutics (NKTR) Financial Statements

Compare
1,599 Followers

Nektar Therapeutics Financial Overview

Nektar Therapeutics's market cap is currently $1.97B. The company's EPS TTM is $-1.78; its P/E ratio is -5.95; Nektar Therapeutics is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-1.77. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 55.23M$ 98.43M$ 90.12M$ 92.06M$ 101.91M
Gross Profit$ 55.23M$ 67.74M$ 53.48M$ 70.42M$ 77.01M
Operating Income$ -130.77M$ -105.20M$ -137.43M$ -240.24M$ -446.10M
EBITDA$ -129.74M$ -86.70M$ -243.11M$ -323.87M$ -461.82M
Net Income$ -164.08M$ -118.96M$ -276.06M$ -368.20M$ -523.84M
Balance Sheet
Cash & Short-Term Investments$ 245.75M$ 255.23M$ 303.62M$ 504.98M$ 733.96M
Total Assets$ 280.41M$ 303.85M$ 398.03M$ 710.60M$ 1.12B
Total Debt$ 148.91M$ 102.56M$ 117.78M$ 131.50M$ 143.18M
Net Debt$ 133.79M$ 58.31M$ 82.50M$ 43.27M$ 117.96M
Total Liabilities$ 190.57M$ 243.11M$ 267.05M$ 343.96M$ 437.68M
Stockholders' Equity$ 89.83M$ 60.74M$ 130.99M$ 366.64M$ 679.51M
Cash Flow
Free Cash Flow$ -208.68M$ -177.18M$ -193.47M$ -309.68M$ -427.65M
Operating Cash Flow$ -208.51M$ -175.71M$ -192.61M$ -304.01M$ -412.66M
Investing Cash Flow$ -1.20M$ 142.57M$ 139.56M$ 365.83M$ 202.78M
Financing Cash Flow$ 180.57M$ 42.12M$ 30.00K$ 1.51M$ 36.24M
Currency in USD

Nektar Therapeutics Earnings and Revenue History

Income Statement >

Nektar Therapeutics Debt to Assets

Balance Sheet >

Nektar Therapeutics Cash Flow

Cash Flow >

Nektar Therapeutics Forecast EPS vs Actual EPS

Earnings >